<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Article Tag Suite 1.1//EN"
  "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink"
         xmlns:mml="http://www.w3.org/1998/Math/MathML"
         article-type="research-article"
         xml:lang="en">
  <front>
    <journal-meta>
      <journal-title-group>
        <journal-title>American Journal of Pharmacy and Health Research</journal-title>
        <abbrev-journal-title abbrev-type="publisher">AJPHR</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="epub">2321-3647</issn>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">AJPHR404001</article-id>
      <title-group>
        <article-title>Microneedles In Drug Delivery and Therapeutics</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Karunakar</surname>
            <given-names>Godugu</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>M</surname>
            <given-names>Manjunath</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gowda</surname>
            <given-names>D V</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Avinash</surname>
            <given-names>Avinash</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Koshy</surname>
            <given-names>Tibey Mary</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tom</surname>
            <given-names>Sweety</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Suryatej</surname>
            <given-names>Karamsetty V M</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Patil</surname>
            <given-names>and Nikhil P</given-names>
          </name>
        </contrib>
      </contrib-group>
      <pub-date pub-type="epub" iso-8601-date="2016-04-01">
        <month>04</month>
        <day>01</day>
        <year>2016</year>
      </pub-date>
      <volume>4</volume>
      <issue>4</issue>
      <abstract>
        <p>The restricted barrier properties of the upmost layer of the skin, the stratum corneum (SC) impose significant limitations for eminent systemic delivery of a broad vary of therapeutic molecules, significantly macromolecules and genetic material. Microneedle delivery has been projected as a method to interrupt the SC barrier perform so as to facilitate effective transport of molecules across the skin. Microneedles are used for the dermal and transdermic delivery of a broad vary of medicine, like tiny relative molecular mass medication, oligonucleotides, DNA, peptides, proteins and inactivated viruses. This strategy involves the employment of metric linear unit sized needles fictitious from completely different materials and victimisation different geometries to make transient binary compound pores across the skin. Following a quick introduction regarding microneedles and its history, this review describes completely different fabrication ways for solid, coated, dissolving and hollow microneedles similarly as their applications and conjointly focuses on recent and potential future developments in microneedle technologies. this can embrace the particularization of progress created in microneedle style, a research of the challenges moon-faced during this field and potential forward methods to embrace the exploitation of microneedle methodologies, whereas considering the inherent safety aspects of such therapeutic tools. Finally, we have a tendency to offer our read on analysis and development that&apos;s required to render microneedles as novel dermal drug delivery technologies clinically helpful within the close to future.</p>
      </abstract>
      <kwd-group kwd-group-type="author">
        <kwd>Microneedles (MN)</kwd>
        <kwd>microelectromechanical systems</kwd>
        <kwd>fabrication</kwd>
        <kwd>casting</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <!-- Full article body not available in metadata-only JATS export. See PDF/HTML galley. -->
  </body>
  <back/>
</article>
